Respiratory Infections News

SAN DIEGO — Fewer patients with sepsis receiving acetaminophen vs. placebo developed acute respiratory distress syndrome, according to research presented at the American Thoracic Society International Conference.

COVID-19 antibodies are significantly reduced by 6 months post-vaccination among patients with immune-mediated inflammatory diseases, according to data published in The Journal of Rheumatology.

Experts say that the management of Q fever, a zoonotic disease caused by Coxiella burnetii, is complicated by the lack of clinical guidance on screening protocols, treatment regimens and durations.

Older adults from underrepresented populations and those with lower incomes were more likely to have risk factors for severe respiratory syncytial virus disease, a study showed.

The CDC has launched an influenza A wastewater online dashboard to help track the potential spread of H5N1 avian influenza, or “bird flu,” which has caused outbreaks among birds and dairy cows.

The FDA has cleared Qiagen’s respiratory syndromic testing panel, the company announced Monday.

Palivizumab was consistently found to be cost-effective as prophylaxis for respiratory syncytial virus disease among neonates on four continents, according to a study presented at the Pediatric Academic Societies Meeting.

Interleukin-17 and IL-23 inhibitors do not increase the risk for tuberculosis reactivation among patients with psoriatic disease who have a latent tuberculosis infection, according to a retrospective study.

Six more dairy cattle herds in the United States have tested positive for avian influenza, bringing the national total to 42 herds, according to the U.S. Department of Agriculture.

TORONTO — Trust in vaccines declined among parents and teenagers over a period of time that included the COVID-19 pandemic, according to survey results presented at the Pediatric Academic Societies Meeting.